Hypertension: Its Outcomes, Its Risks, and Potential Treatments
Hypertension: Its Outcomes, Its Risks, and Potential Treatments
New data on the first entirely new class of antihypertensive treatment in 10 years were presented at the American Society of Hypertension Annual Meeting this month. Also, there was more argument from the ALLHAT investigators about diuretics, hypertension, and heart failure, followed by a contradictory report that a history of arterial hypertension does not affect mortality in patients who are hospitalized with congestive heart failure. A very interesting analysis of ethnic differences in susceptibility to adverse drug reactions to antihypertensive drugs was followed by the perhaps surprising finding that there is no relation between reduction in blood pressure and reduction in levels of C-reactive protein. Finally, new US guidelines for primary prevention of ischemic stroke stress blood pressure reduction and a brief clarification about caffeine in children, which raises blood pressure but lowers heart rate during exercise.
New data on the first entirely new class of antihypertensive treatment in 10 years were presented at the American Society of Hypertension Annual Meeting this month. Also, there was more argument from the ALLHAT investigators about diuretics, hypertension, and heart failure, followed by a contradictory report that a history of arterial hypertension does not affect mortality in patients who are hospitalized with congestive heart failure. A very interesting analysis of ethnic differences in susceptibility to adverse drug reactions to antihypertensive drugs was followed by the perhaps surprising finding that there is no relation between reduction in blood pressure and reduction in levels of C-reactive protein. Finally, new US guidelines for primary prevention of ischemic stroke stress blood pressure reduction and a brief clarification about caffeine in children, which raises blood pressure but lowers heart rate during exercise.
Source...